Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer
Authors
Keywords
-
Journal
Journal of Cachexia Sarcopenia and Muscle
Volume 9, Issue 2, Pages 315-325
Publisher
Wiley
Online
2018-01-10
DOI
10.1002/jcsm.12267
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer
- (2017) Tora S. Solheim et al. Journal of Cachexia Sarcopenia and Muscle
- Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer
- (2017) Carolina Palmela et al. Journal of Gastric Cancer
- The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma
- (2016) Katie E. Rollins et al. CLINICAL NUTRITION
- Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients
- (2016) Poorna Anandavadivelan et al. CLINICAL NUTRITION
- Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer
- (2016) Bjørg Sjøblom et al. CLINICAL NUTRITION
- Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review
- (2016) Shlomit Strulov Shachar et al. EUROPEAN JOURNAL OF CANCER
- Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer
- (2016) Susanne Blauwhoff-Buskermolen et al. JOURNAL OF CLINICAL ONCOLOGY
- Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
- (2016) Jennifer S Temel et al. LANCET ONCOLOGY
- Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials
- (2016) Eric J. Roeland et al. SUPPORTIVE CARE IN CANCER
- Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients
- (2016) Iris J.G. Rutten et al. Journal of Cachexia Sarcopenia and Muscle
- Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer
- (2015) Yuji Miyamoto et al. ANNALS OF SURGICAL ONCOLOGY
- Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer
- (2015) B.H.L. Tan et al. EJSO
- Comparing Two Classifications of Cancer Cachexia and Their Association with Survival in Patients with Unresected Pancreatic Cancer
- (2015) Nima Wesseltoft-Rao et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer
- (2015) NAOMI HAYASHI et al. ONCOLOGY REPORTS
- Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma
- (2015) Pranav Sharma et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015
- (2015) Stephan von Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- Sarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma
- (2015) Hiroshi Fukushima et al. PLoS One
- Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer
- (2015) Yuji Miyamoto et al. PLoS One
- Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer
- (2014) Guro B. Stene et al. ACTA ONCOLOGICA
- Measurement of skeletal muscle radiation attenuation and basis of its biological variation
- (2014) J. Aubrey et al. Acta Physiologica
- Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer
- (2014) Connie Yip et al. EUROPEAN RADIOLOGY
- Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma
- (2014) Savita Joglekar et al. JOURNAL OF SURGICAL ONCOLOGY
- Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?
- (2014) David R. Fogelman et al. Journal of Cachexia Sarcopenia and Muscle
- Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
- (2013) Carla M Prado et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies
- (2013) Sami Antoun et al. CANCER
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
- (2013) Adrian S Dobs et al. LANCET ONCOLOGY
- Evidence base for multimodal therapy in cachexia
- (2013) Tora S. Solheim et al. Current Opinion in Supportive and Palliative Care
- Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma
- (2012) C M M Prado et al. BRITISH JOURNAL OF CANCER
- Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery
- (2012) J R Lieffers et al. BRITISH JOURNAL OF CANCER
- Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia
- (2012) Katie M. Di Sebastiano et al. BRITISH JOURNAL OF NUTRITION
- Relationships Among Body Mass Index, Longitudinal Body Composition Alterations, and Survival in Patients With Locally Advanced Pancreatic Cancer Receiving Chemoradiation: A Pilot Study
- (2012) Shalini Dalal et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer
- (2011) Sherif Awad et al. CLINICAL NUTRITION
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis
- (2011) Peter D. Peng et al. HPB
- Cancer Cachexia: Mechanisms and Clinical Implications
- (2011) Claire L. Donohoe et al. Gastroenterology Research and Practice
- Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres
- (2010) M Pressoir et al. BRITISH JOURNAL OF CANCER
- Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study
- (2010) Sami Antoun et al. JOURNAL OF CLINICAL ONCOLOGY
- Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
- (2009) B. H.L. Tan et al. CLINICAL CANCER RESEARCH
- EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary
- (2009) Milena Sant et al. EUROPEAN JOURNAL OF CANCER
- A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
- (2008) Marina Mourtzakis et al. Applied Physiology Nutrition and Metabolism
- Cancer cachexia: Developing multimodal therapy for a multidimensional problem
- (2008) K.C.H. Fearon EUROPEAN JOURNAL OF CANCER
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
- Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients
- (2008) Federico Bozzetti et al. SUPPORTIVE CARE IN CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search